Search This Blog

Thursday, November 7, 2019

Sarepta Therapeutics EPS misses by $0.22, beats on revenue

Sarepta Therapeutics (NASDAQ:SRPT): Q3 Non-GAAP EPS of -$1.14 misses by $0.22; GAAP EPS of -$1.70 misses by $0.35.
Revenue of $99.04M (+26.2% Y/Y) beats by $0.55M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)